Wale(s) of experience
Arthurian plans 10-12 drug, Dx, medtech investments for Welsh fund
Wale(s) of experience
A group of seasoned life science investors, academics and former executives surfaced last week as board members of Sir Chris Evans' new investment firm Arthurian Life Sciences. The group's first task is managing
